Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
48.0%
% of BBH's 27 holdings also in PBE
42.9%
% of PBE's 28 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBH |
Weight in PBE |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 10.9% | 5.1% | 5.1% | |
REGENERON PHARMACEUTICALS | 6.5% | 4.9% | 4.9% | |
AMGEN INC | 15.3% | 4.7% | 4.7% | |
ILLUMINA INC | 4.4% | 5.1% | 4.4% | |
NATERA INC | 4.0% | 5.1% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to PBE
VERTEX PHARMACEUTICALS INC | 10.8% | |
AMGEN INC | 10.6% | |
GILEAD SCIENCES INC | 5.8% | |
ARGENX SE ADR | 5.6% | |
IQVIA HOLDINGS INC | 4.6% | |
ICON PLC | 3.5% | |
ALNYLAM PHARMACEUTICALS INC | 3.3% | |
BIONTECH SE SPONSORED ADR | 2.7% | |
MODERNA, INC. | 2.6% | |
INSMED INC | 2.2% |
BBH Underweight Relative to PBE
UNITED THERAPEUTICS CORP | -5.0% | |
INCYTE CORP | -3.2% | |
VERACYTE INC | -2.9% | |
ACADIA PHARMACEUTICALS INC | -2.9% | |
BIOCRYST PHARMACEUTICALS INC | -2.9% | |
CATALYST PHARMACEUTICAL PART | -2.8% | |
HALOZYME THERAPEUTICS INC | -2.8% | |
BLUEPRINT MEDICINES CORP. | -2.7% | |
COLLEGIUM PHARMACEUTICAL, INC. | -2.7% | |
EXELIXIS INC | -2.7% |